Medicare Enrolled
Dr. Shailesh Satpute, MD, PHD
Hematology & Oncology · Atlanta, GA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Satpute from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Satpute?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Satpute
Dr. Shailesh Satpute is a hematology & oncology specialist in Atlanta, GA, with 15 years of NPI registration. Based on federal Medicare data, Dr. Satpute performed 996 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Satpute received a total of $14,287 from 78 pharmaceutical and/or device companies across 744 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Satpute is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 15 years of NPI registration
▲ Top 38% volume in GA
$14,287 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗996
Medicare services
Top 38% in GA for hematology & oncology
Not available
Unique patients (not deduplicated)
$71
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
652 | $64 | $319 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
140 | $57 | $248 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
77 | $99 | $458 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
46 | $130 | $461 |
| New patient office visit, complex (60-74 min) | 32 | $125 | $656 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
24 | $82 | $300 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
13 | $33 | $224 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
12 | $91 | $344 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$14,287
Total received (2018-2024)
Avg $2,041/year across 7 years
Top 22% in GA for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
78
Companies
744
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,367
2023
$2,496
2022
$2,720
2021
$585
2020
$1,721
2019
$2,928
2018
$2,469
Payments by company (2024)
PFIZER INC.
$171
Daiichi Sankyo Inc.
$140
AstraZeneca Pharmaceuticals LP
$106
Adaptive Biotechnologies Corporation
$87
Celgene Corporation
$71
ABBVIE INC.
$67
Takeda Pharmaceuticals U.S.A., Inc.
$64
GlaxoSmithKline, LLC.
$63
GENZYME CORPORATION
$53
Janssen Biotech, Inc.
$52
PUMA BIOTECHNOLOGY, INC.
$47
Novartis Pharmaceuticals Corporation
$45
Alexion Pharmaceuticals, Inc.
$35
Astellas Pharma US Inc
$30
Bayer Healthcare Pharmaceuticals Inc.
$29
Ipsen Biopharmaceuticals, Inc
$29
Blueprint Medicines Corporation
$26
Eisai Inc.
$25
Merck Sharp & Dohme LLC
$24
BeiGene USA, Inc.
$24
Mirati Therapeutics, Inc.
$24
Stemline Therapeutics Inc.
$23
Karyopharm Therapeutics Inc.
$22
Genentech USA, Inc.
$22
Pharmacosmos Therapeutics Inc.
$22
Deciphera Pharmaceuticals Inc.
$21
Legend Biotech USA Inc.
$21
Lilly USA, LLC
$21
Top 3 companies account for 30.6% of 2024 payments
All-time payments by company (2018-2024) ›
Exelixis Inc.
$1,495
Janssen Biotech, Inc.
$1,170
Novartis Pharmaceuticals Corporation
$831
E.R. Squibb & Sons, L.L.C.
$784
AstraZeneca Pharmaceuticals LP
$780
Celgene Corporation
$565
PFIZER INC.
$542
Genentech USA, Inc.
$492
Incyte Corporation
$438
Amgen Inc.
$428
Takeda Pharmaceuticals U.S.A., Inc.
$408
Seagen Inc.
$397
Astellas Pharma US Inc
$387
Lilly USA, LLC
$373
Merck Sharp & Dohme Corporation
$301
Eisai Inc.
$290
GlaxoSmithKline, LLC.
$261
EISAI INC.
$244
Puma Biotechnology, Inc.
$237
Merck Sharp & Dohme LLC
$223
Alexion Pharmaceuticals, Inc.
$207
Daiichi Sankyo Inc.
$189
ABBVIE INC.
$142
Deciphera Pharmaceuticals Inc.
$136
GENZYME CORPORATION
$131
TESARO, Inc.
$116
Regeneron Healthcare Solutions, Inc.
$116
Bayer HealthCare Pharmaceuticals Inc.
$114
Rigel Pharmaceuticals, Inc.
$109
Adaptive Biotechnologies Corporation
$107
Janssen Pharmaceuticals, Inc
$92
Seattle Genetics, Inc.
$92
Ipsen Biopharmaceuticals, Inc
$88
Pharmacyclics LLC, an AbbVie Company
$87
BeiGene USA, Inc.
$87
Pharmacyclics LLC, An AbbVie Company
$85
AbbVie, Inc.
$85
Foundation Medicine, Inc.
$82
TerSera Therapeutics LLC
$80
Clovis Oncology, Inc.
$74
Coherus Biosciences Inc.
$72
AMAG Pharmaceuticals, Inc.
$71
Kyowa Kirin, Inc.
$69
Blueprint Medicines Corporation
$66
Mirati Therapeutics, Inc.
$64
EMD Serono, Inc.
$63
SANOFI-AVENTIS U.S. LLC
$60
SERVIER PHARMACEUTICALS LLC
$55
MEDIVATION FIELD SOLUTIONS LLC
$52
TAIHO ONCOLOGY, INC.
$51
Lexicon Pharmaceuticals, Inc.
$51
Apellis Pharmaceuticals, Inc.
$50
PUMA BIOTECHNOLOGY, INC.
$47
Bayer Healthcare Pharmaceuticals Inc.
$45
Kite Pharma, Inc.
$39
Biocompatibles, Inc.
$38
Karyopharm Therapeutics Inc.
$37
INSYS Therapeutics Inc
$37
Pharmacosmos Therapeutics Inc.
$35
ADC Therapeutics America, Inc.
$33
Gilead Sciences, Inc.
$33
Array BioPharma Inc.
$31
Emmaus Medical, Inc.
$30
Agios Pharmaceuticals, Inc.
$26
Dova Pharmaceuticals
$26
AbbVie Inc.
$25
Advanced Accelerator Applications
$24
Stemline Therapeutics Inc.
$23
Legend Biotech USA Inc.
$21
Acrotech Biopharma LLC
$21
Alnylam Pharmaceuticals Inc.
$20
Boehringer Ingelheim Pharmaceuticals, Inc.
$17
Taiho Oncology, Inc.
$16
G1 Therapeutics, Inc.
$16
CTI BioPharma Corp.
$16
Spectrum Pharmaceuticals Inc.
$16
SECURA BIO, INC.
$13
Secura Bio, Inc.
$11
Top 3 companies account for 24.5% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · AFINITOR · ALIMTA · AYVAKIT · Abraxane · Alecensa · Avastin · BALVERSA · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Blincyto · Braftovi · CABLIVI · CABOMETYX · CALQUENCE · CEREZYME · COPIKTRA · COSELA · CYRAMZA · Cabometyx · Columvi · DARZALEX · Doptelet · ELIQUIS · ELREXFIO · EMPLICITI · ENHERTU · EPKINLY · ERLEADA · Empaveli · Endari · Enhertu · Erleada · FARESTON · FARYDAK · FERAHEME · FOUNDATIONONE · FOUNDATIONONE CDX · GAZYVA · GILOTRIF · GIVLAARI · Halaven · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · Imbruvica · JADENU · JAKAFI · JAYPIRCA · JEMPERLI · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · Kadcyla · Kyprolis · LIBTAYO · LONSURF · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lunsumio · MARQIBO · MEKINIST · MONJUVI · MONOFERRIC · MVASI · MYLOTARG · NERLYNX · NINLARO · Nerlynx · Neulasta · Nexavar · Nplate · Nubeqa · OJJAARA · ONUREG · OPDIVO · OPDUALAG · Onivyde · Orserdu · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · POTELIGEO · PROMACTA · PYRUKYND · Padcev · Perjeta · Phesgo · Pomalyst · Prolia · QINLOCK · REBLOZYL · RETEVMO · RYDAPT · Revlimid · Rezlidhia · Rubraca · SANCUSO · SANDOSTATIN · SARCLISA · SCEMBLIX · SOLIRIS · SOMATULINE DEPOT · SPRYCEL · SUTENT · SYNDROS · Somatuline Depot · Stivarga · TABRECTA · TAGRISSO · TALVEY · TASIGNA · TECENTRIQ · TEPMETKO · THERASPHERE-BIO · TIBSOVO · TIVDAK · TRINTELLIX · TUKYSA · Tavalisse · Tibsovo · Trodelvy · ULTOMIRIS · Udenyca · VENCLEXTA · VERZENIO · Venclexta · Vitrakvi · Vonjo · XALKORI · XARELTO · XPOVIO · XTANDI · Xermelo · Xofigo · Xospata · Xtandi · Yescarta · ZEJULA · ZYTIGA · Zevalin · Zoladex · clonoSEQ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematology & oncology specialists in nearby ZIP areas
185
County median income
$91,490
Nearest hospital to ZIP centroid (approximate)
SAINT JOSEPH'S HOSPITAL OF ATLANTA, INC
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Satpute is a clinical cardiology specialist, with moderate Medicare volume, with 15 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Satpute experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Satpute performed 652 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Satpute receive payments from pharmaceutical companies?
Yes. Dr. Satpute received a total of $14,287 from 78 companies across 744 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Satpute's costs compare to other hematology & oncology specialists in Atlanta?
Dr. Satpute's average Medicare payment per service is $71. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Satpute) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Atlanta
Browse hematology & oncology specialists in Atlanta ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in GA
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in GA
Which GA hematology & oncology specialists receive the most from drug and device companies.
By company
Exelixis Inc. Payments to Doctors
See all physicians who received payments from Exelixis Inc.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology